醫療保健 · Healthcare
開啟互動頁面（K 線、成交價圖）Open interactive page →
ACRV · Acrivon Therapeutics, Inc.
內部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
Acrivon Therapeutics, Inc.（ACRV）內部人交易：2026-07-01 至 2026-10-22，內部人公開市場買入 —、賣出 $40K；高管董事有效買入 —、有效賣出 —。最近申報 2026-10-07。
買入 Bought—
賣出 Sold$40K
有效買入 Effective bought—
有效賣出 Effective sold—
最近申報 Recent filings
| 交易日 | 內部人 | 類型 | 股數 | 價格 | 金額 | |
|---|---|---|---|---|---|---|
| 2026-10-05 | Miller Mary Chief Legal Officer | 賣出 Sell | 294 | $1.99 | $585 | SEC |
| 2026-08-25 | Blume-Jensen Peter Director, EVP - Business Operations, President and CEO | 賣出 Sell | 14,036 | $2.21 | $31K | SEC |
| 2026-08-18 | Blume-Jensen Peter Director, EVP - Business Operations, President and CEO | 賣出 Sell | 1,713 | $2.01 | $3K | SEC |
| 2026-08-18 | Devroe Eric Chief Operating Officer | 賣出 Sell | 604 | $2.01 | $1K | SEC |
| 2026-08-18 | Gamelin Erick Chief Development Officer | 賣出 Sell | 400 | $2.01 | $804 | SEC |
| 2026-08-18 | Miller Mary Chief Legal Officer | 賣出 Sell | 185 | $2.01 | $372 | SEC |
| 2026-08-18 | Peterson Katharine Chief Accounting Officer | 賣出 Sell | 101 | $2.01 | $203 | SEC |
| 2026-08-04 | Levy Adam D. Chief Financial Officer | 賣出 Sell | 1,142 | $1.57 | $2K | SEC |
| 2026-07-21 | Miller Mary Chief Legal Officer | 賣出 Sell | 573 | $1.76 | $1K | SEC |
「有效」= 高管或董事的公開市場主動買賣，排除 10b5-1 計劃、行權賣出、繳稅賣出、IPO/認購等。
擬出售 Form 144
| 預計出售日 | 申報人 | 股數 | 約金額 | |
|---|---|---|---|---|
| 2026-08-25 | Blume-Jensen Peter Officer, Director | 14,036 | $31K |
內部人 Insiders
Miller Mary、Blume-Jensen Peter、Devroe Eric、Gamelin Erick、Peterson Katharine、Levy Adam D.